Showing 1,381 - 1,400 results of 100,247 for search '(( 5 point decrease ) OR ( 5 ((step decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.47s Refine Results
  1. 1381

    Change in percentage of pO values ≤5 mmHg by Bernardino Clavo (3925)

    Published 2011
    “…</p> During ozone therapy, a decrease in percentage of pO values ≤5 mmHg at each measurement time-point was observed in the tumors of patients: = before ozone therapy; = after session #1 ( = 0.002); = 48 h after session #2 ( = 0.045); = after session #3 ( = 0.033). …”
  2. 1382
  3. 1383

    Lowering Melting Points in Asymmetrically Substituted Salen-Copper(II) Complexes Exhibiting Mesomorphic Behavior. Structure of the Mesogen Cu(5-hexyloxySalen) by Reinhard Paschke (553784)

    Published 2002
    “…In comparison with their symmetrical analogues, unsymmetrically substituted Cu−Salen complexes show mesophases with lowered melting points. For terminally substituted complexes, symmetrical ones (R<sup>1</sup> = R<sup>2</sup>) have only an S<sub>A</sub> phase, while for unsymmetrical alkoxy substitution a monotropic S<sub>E</sub> phase occurs and the melting temperature decreases with no loss in mesophase stability. …”
  4. 1384

    Lowering Melting Points in Asymmetrically Substituted Salen-Copper(II) Complexes Exhibiting Mesomorphic Behavior. Structure of the Mesogen Cu(5-hexyloxySalen) by Reinhard Paschke (553784)

    Published 2002
    “…In comparison with their symmetrical analogues, unsymmetrically substituted Cu−Salen complexes show mesophases with lowered melting points. For terminally substituted complexes, symmetrical ones (R<sup>1</sup> = R<sup>2</sup>) have only an S<sub>A</sub> phase, while for unsymmetrical alkoxy substitution a monotropic S<sub>E</sub> phase occurs and the melting temperature decreases with no loss in mesophase stability. …”
  5. 1385

    Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Stud... by Ken Ohta (727449)

    Published 2015
    “…Commonly reported AEs with tiotropium 5 μg, 2.5 μg and placebo were nasopharyngitis (48.2%, 44.7%, 42.1%), asthma (28.9%, 29.8%, 38.6%), decreased PEFR (15.8%, 7.9%, 21.1%), bronchitis (9.6%, 13.2%, 7.0%), pharyngitis (7.9%, 13.2%, 3.5%) and gastroenteritis (10.5%, 3.5%, 5.3%). …”
  6. 1386

    Decreased Sho levels in ScN2a-Sho cells. by Joel C. Watts (195735)

    Published 2011
    “…(<b>C</b>) Quantification of Sho levels in ScN2a-Sho-1 (<i>n</i> = 10) and ScN2a-Sho-2 (<i>n</i> = 5) subclones revealed a significant decrease of 40–45% compared to the uninfected parental cell line (<i>n</i> = 15) (***<i>P</i><0.001).…”
  7. 1387
  8. 1388
  9. 1389
  10. 1390
  11. 1391

    Progesterone decreased vanillin-induced responses in the ORNs of p5 mice. by Ninthujah Kanageswaran (683924)

    Published 2016
    “…<p>(A) Representative responses to 100 μM vanillin were obtained from Olfr73 positive ORNs in tissue slices using patch-clamp recordings in a voltage-clamp configuration (V<sub>h</sub> = -56 mV). …”
  12. 1392

    Estradiol decreased vanillin-induced responses in the ORNs of p5 mice. by Ninthujah Kanageswaran (683924)

    Published 2016
    “…<p>(A) Representative responses to 100 μM vanillin from Olfr73 positive ORNs in tissue slices were obtained from patch-clamp recordings set to a voltage-clamp configuration (V<sub>h</sub> = -56 mV). …”
  13. 1393
  14. 1394
  15. 1395
  16. 1396

    Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease by Jinglu Yang (6391913)

    Published 2019
    “…</p> <p><i>Results</i>: A decreased expression of TGR5 in M1 macrophages was observed in active VKH patients as compared with normal controls. …”
  17. 1397
  18. 1398
  19. 1399
  20. 1400